These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25891739)

  • 21. [Case report of introducing MMF and steroids as an immunosuppressive therapy after living-donor liver transplantation for a patient with the diabetic nephropathy].
    Kuramitsu S; Iguchi T; Ninomiya M; Yamashita Y; Harimoto N; Ikegami T; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Kawanaka H; Ikeda T; Furuta T; Tamada R; Maehara Y
    Fukuoka Igaku Zasshi; 2014 Mar; 105(3):79-83. PubMed ID: 25000660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.
    Vanhove T; Kuypers D; Claes KJ; Evenepoel P; Meijers B; Naesens M; Vanrenterghem Y; Cornelis T; Bammens B
    Transpl Int; 2013 Aug; 26(8):813-21. PubMed ID: 23746202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: prediction of occurrence of leukopenia.
    Hao C; Anwei M; Bing C; Baiyong S; Weixia Z; Chuan S; Erzhen C; Xiaxing D; Weihua Q; Weiping Y; Chenghong P; Hongwei L
    Liver Transpl; 2008 Aug; 14(8):1165-73. PubMed ID: 18668650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.
    Guethoff S; Stroeh K; Grinninger C; Koenig MA; Kleinert EC; Rieger A; Mayr T; von Ziegler F; Reichart B; Hagl C; Schramm R; Kaczmarek I; Meiser BM
    J Heart Lung Transplant; 2015 May; 34(5):634-42. PubMed ID: 25701373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
    Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
    Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limits to intensified mycophenolate mofetil dosing in kidney transplantation.
    Kiberd BA; Lawen J; Daley C
    Ther Drug Monit; 2012 Dec; 34(6):736-8. PubMed ID: 23007746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic) in liver transplant patients with gastrointestinal side effects.
    Robaeys G; Cassiman D; Verslype C; Monbaliu D; Aerts R; Pirenne J; Nevens F
    Transplant Proc; 2009 Mar; 41(2):610-3. PubMed ID: 19328938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium.
    Ortega F; Sánchez-Fructuoso A; Cruzado JM; Gómez-Alamillo JC; Alarcón A; Pallardó L; Morales JM; Oliver J; Guinea G;
    Transplantation; 2011 Aug; 92(4):426-32. PubMed ID: 21760569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteric-coated mycophenolate sodium reduces gastrointestinal symptoms in renal transplant patients.
    Burg M; Säemann MD; Wieser C; Kramer S; Fischer W; Lhotta K
    Transplant Proc; 2009 Dec; 41(10):4159-64. PubMed ID: 20005359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirolimus: a switch option for mycophenolate mofetil-induced leukopenia in renal transplant recipients.
    Shin BC; Chung JH; Kim HL
    Transplant Proc; 2013 Oct; 45(8):2968-9. PubMed ID: 24157014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep Ulcers in the Ileum Associated with Mycophenolate Mofetil.
    Sonoda A; Wada K; Mizukami K; Fukuda K; Shuto M; Okamoto K; Ogawa R; Okimoto T; Murakami K
    Intern Med; 2017 Nov; 56(21):2883-2886. PubMed ID: 28943566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients.
    Bilbao I; Castells L; Rojas L; Cancino J; Dopazo C; Castro E; Pou L; Andino R; Margarit C
    Int Immunopharmacol; 2006 Dec; 6(13-14):1977-83. PubMed ID: 17161351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil-related gastrointestinal mucosal injury in multivisceral transplantation.
    Delacruz V; Weppler D; Island E; Gonzalez M; Tryphonopoulos P; Moon J; Smith L; Tzakis A; Ruiz P
    Transplant Proc; 2010; 42(1):82-4. PubMed ID: 20172286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction.
    Jain A; Sharma R; Ryan C; Tsoulfas G; Orloff M; Abt P; Kashyap R; Batzold P; Sauberman L; Safadjou S; Graham M; Bozorgzadeh A
    Liver Transpl; 2008 Feb; 14(2):202-9. PubMed ID: 18236395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysis.
    Salvadori M; Bertoni E; Budde K; Holzer H; Civati G; Lien B; Arns W
    Transplant Proc; 2010 May; 42(4):1325-8. PubMed ID: 20534293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive drugs in paediatric liver transplantation.
    van Mourik ID; Kelly DA
    Paediatr Drugs; 2001; 3(1):43-60. PubMed ID: 11220404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.